Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of CRISPR Therapeutics AG (NASDAQ: CRSP) closed at $50.43 in the last session, down -4.88% from day before closing price of $53.02. In other words, the price has decreased by -$4.88 from its previous closing price. On the day, 2.97 million shares were traded.
Ratios:
We take a closer look at CRSP’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 22.07 and its Current Ratio is at 22.07. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.11.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Evercore ISI on February 14, 2025, Upgraded its rating to Outperform and sets its target price to $99 from $60 previously.
On February 12, 2025, TD Cowen Upgraded its rating to Hold which previously was Sell but kept the price unchanged to $35.
On February 03, 2025, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $65.H.C. Wainwright initiated its Buy rating on February 03, 2025, with a $65 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 18 ’25 when Kulkarni Samarth sold 11,640 shares for $55.05 per share. The transaction valued at 640,782 led to the insider holds 196,901 shares of the business.
Kulkarni Samarth sold 6,928 shares of CRSP for $365,798 on Feb 19 ’25. The Chief Executive Officer now owns 189,973 shares after completing the transaction at $52.80 per share. On Feb 19 ’25, another insider, Bruno Julianne, who serves as the Chief Operating Officer of the company, sold 333 shares for $52.80 each. As a result, the insider received 17,582 and left with 7,062 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 115.94 while its Price-to-Book (P/B) ratio in mrq is 2.24.
Stock Price History:
Over the past 52 weeks, CRSP has reached a high of $91.10, while it has fallen to a 52-week low of $36.52. The 50-Day Moving Average of the stock is 17.81%, while the 200-Day Moving Average is calculated to be 1.89%.
Shares Statistics:
A total of 85.74M shares are outstanding, with a floating share count of 82.09M. Insiders hold about 4.30% of the company’s shares, while institutions hold 69.43% stake in the company.
